¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cellular infiltration"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cellular infiltration
    ¼¼Æ÷ħÀ±
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycogenic infiltration
    ´ç¿øÄ§À±
  • infiltration
    ħÀ±, ħ½À
  • infiltration analgesia
    ħÀ±ÁøÅë
  • infiltration anesthesia
    ħÀ±¸¶Ãë
  • lipid infiltration
    ÁöÁúħÀ±
  • local infiltration
    ±¹¼ÒħÀ±
  • marrow infiltration
    °ñ¼öħÀ±
  • primary infiltration
    ÃʱâħÀ±
  • purulent infiltration
    °í¸§Ä§À±, È­³óħÀ±
  • cellular
    ¼¼Æ÷-
  • cellular adhesiveness
    ¼¼Æ÷ºÎÂø¼º
  • cellular aging
    ¼¼Æ÷³ëÈ­
  • cellular antibody
    ¼¼Æ÷Ç×ü
  • cellular cast
    ¼¼Æ÷¿øÁÖ
  • cellular cementum
    ¼¼Æ÷½Ã¸àÆ®Áú
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cellular type
    ¼¼Æ÷Çü
  • infiltration anesthesia
    ħÀ±¸¶Ãë
  • infiltration
    ħÀ±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cellular infiltration
    ¼¼Æ÷ħÀ±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • infiltration analgesia
    ħÀ±ÁøÅë
  • infiltration anesthesia
    ħÀ±¸¶Ãë
  • glycogenic infiltration
    ±Û¸®ÄÚ°ÕħÀ±
  • infiltration
    ħÀ±
  • lipid infiltration
    ÁöÁúħÀ±
  • local infiltration
    ±¹¼ÒħÀ±
  • marrow infiltration
    °ñ¼öħÀ±
  • primary infiltration
    ÃʱâħÀ±
  • purulent infiltration
    °í¸§Ä§À±, È­³óħÀ±
  • cellular adhesiveness
    ¼¼Æ÷ºÎÂø¼º
  • cellular aging
    ¼¼Æ÷³ëÈ­
  • cellular antibody
    ¼¼Æ÷Ç×ü
  • cellular
    ¼¼Æ÷-
  • cellular cartilage
    ¼¼Æ÷¿¬°ñ
  • cellular cast
    ¼¼Æ÷¿ø±âµÕ, ¼¼Æ÷¿øÁÖ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high cellular component
    °í¼¼Æ÷ ±¸¼º ¼ººÐ
  • hypersensitivity, cellular
    ¼¼Æ÷¼º °ú¹Î¹ÝÀÀ
  • impaired cellular immunity
    ¼¼Æ÷¼º ¸é¿ªºÎÀü(á¬øààõØóæ¹ÝÕîï).
  • PIE syndrome => pulmonary infiltration with eosinophilia syndrome
    È£»ê±¸Áõ°¡¼º ÆóħÀ± ÁõÈıº
  • glycogenic infiltration
    ±Û¸®ÄÚ°ÕħÀ±.
  • primary infiltration
    ÃʱâħÀ±
  • pulmonary infiltration
    ÆóħÀ±(øËöÙëÈ).
  • pulmonary infiltration
    ÆóħÀ±(øËöÙëÈ)
  • purulent infiltration
    È­³ó¼º ħÀ±(ûùÒÛàõ öÙëÈ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cellular infiltration
    ¼¼Æ÷ħÀ±(¡­öÙëÈ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycogenic infiltration
    ±Û¸®ÄÚ°ÕħÀ±.
  • infiltration analgesia
    ħÀ±¼º ¹«Åë°¢(Áõ)(¡­àõÙí÷ÔÊÆñø).
  • infiltration anesthesia
    ħÀ±¸¶Ãë(¹ý)(¡­Ø«ö­ Ûö).
  • infiltration of neutrophils
    Áß¼º±¸Ä§À±
  • lipid infiltration
    ÁöÁúħÀ±(¡­öÕëÈ).
  • local infiltration
    ±¹¼ÒħÀ±(¹ý).
  • lymphocytic infiltration
    ¸²ÇÁ±¸ ħÀ±
  • marrow infiltration
    °ñ¼öħÀ±
  • paraneural infiltration
    ½Å°æÁÖÀ§Ä§À±¸¶Ãë(ãêÌèñ²êÌöÕëÈØ«ö­).
  • perihilar infiltration
    Æó¹®ÁÖÀ§ ħÀ±
  • periurethral infiltration
    ¿äµµÁÖÀ§Ä§À±.
  • primary infiltration
    ÃʱâħÀ±
  • pulmonary infiltration
    ÆóħÀ±(øËöÙëÈ).
  • pulmonary infiltration
    ÆóħÀ±(øËöÙëÈ)
  • purulent infiltration
    È­³ó¼º ħÀ±(ûùÒÛàõ öÙëÈ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Cellular deficiency (Acallosal cerebrum)
    ¼¼Æ÷°áÇÌ (³úµéº¸°á¿©³ú)
    [¿¾ ¿ë¾î] ¼¼Æ÷°áÇÌ
  • Cellular granule
    ¼¼Æ÷°ú¸³
    [¿¾ ¿ë¾î] ¼¼Æ÷°ú¸³
  • Cellular process
    ¼¼Æ÷µ¹±â
    [¿¾ ¿ë¾î] ¼¼Æ÷µ¹±â
  • Cellular islands
    ¼¼Æ÷¼¶
    [¿¾ ¿ë¾î] ¼¼Æ÷µµ
  • Cellular connective tissue
    ¼¼Æ÷¼º°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] ¼¼Æ÷¼º°áÇÕÁ¶Á÷
  • Cellular membrane
    ¼¼Æ÷¼º¸·
    [¿¾ ¿ë¾î] ¼¼Æ÷¼º¸·
  • Cellular cementum
    ¼¼Æ÷½Ã¸àÆ®Áú
    [¿¾ ¿ë¾î] ¼¼Æ÷¼º½Ã¸àÆ®Áú
  • Cellular layer
    ¼¼Æ÷ÆÇ
    [¿¾ ¿ë¾î] ¼¼Æ÷Ãþ
  • Cellular invagination
    ¼¼Æ÷ÇÔÀÔ
    [¿¾ ¿ë¾î] ¼¼Æ÷ÇÔÀÔ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fatty infiltration
    Áö¹æÄ§À±(ò·Û¸öÕëÈ)
  • antibody dependent cellular cytotoxicity
    Ç×üÀÇÁ¸ÀÚ¸® ¼¼Æ÷¼º¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øààõá¬øàÔ¸àõ)
  • cellular immunity
    ¼¼Æ÷¸é¿ª(á¬øàØóæ¹)
  • cellular oncogene
    ¼¼Æ÷ ¾ÏÀ¯ÀüÀÚ(á¬øàäßë¶îîí­)
  • cellular respiration
    ¼¼Æ÷È£Èí(á¬øàû¼ýå)
  • cellular retinol-binding protein
    ¼¼Æ÷(á¬øà) ·¹Æ¼³î°áÇÕ(Ì¿ùê) ´Ü¹éÁú(Ó±ÛÜòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high cellular component
    °í¼¼Æ÷±¸¼º¼ººÐ
  • amyloid infiltration
    ¾Æ¹Ð·ÎÀ̵åħÀ±
  • fat infiltration
    Áö¹æÄ§À±
  • granulomatous infiltration
    À°¾ÆÁ¾¼ºÄ§À±
  • infiltration
    ħÀ±
  • leukemic infiltration
    ¹éÇ÷º´¼º ħÀ±
  • local infiltration
    ±¹¼ÒħÀ±(¹ý)
  • perihilar infiltration
    Æó¹®ÁÖÀ§Ä§À±
  • primary infiltration
    ÃʱâħÀ±
  • pulmonary infiltration
    ÆóħÀ±
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PIE   1) Post-Infectious Encephalomyelitis
  2) Pulmonary Interstitial Emphysema;...
CSI calculus surface index; cancer serum index; cavernous sinus infiltration; cervical spine injury; che...
PIE postinfectious encephalomyelitis preimplantation embryo; prosthetic infectious endocarditis; pulmona...
PLT pancreatic lymphocytic infiltration; platelet; primed lymphocyte test; primed lymphocyte typing; psi...
PVI patient video interview; peripheral vascular insufficiency; perivascular infiltration; positron volu...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
I-CAM Inter-Cellular-Adhesion-Molecule
ACR Acute cellular rejection
ADCC Antibody Dependent Cellular Cytotoxicity
ADCC Antibody dependent cellular cytotoxic
Ca2+ Cellular
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cellular infiltration
    ¼¼Æ÷ ħÀ±
    ¼¼Æ÷°¡ ħÀ±¿¡ ÀÇÇÏ¿© Ä§ÂøµÈ °Í.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • amyloid infiltration
    ¾Æ¹Ð·ÎÀ̵å ħÀ±
  • calcic infiltration
    ¼®È¸ ħÀ±
  • fat infiltration
    Áö¹æ ħÀ±
  • fatty infiltration
    Áö¹æ ħÀ±
  • infiltration
    ħÀ±
    Á¶Á÷À̳ª ¼¼Æ÷¿¡ Á¤»óÀÌ ¾Æ´Ñ ¹°ÁúÀ̳ª ºñÁ¤»óÀûÀ¸·Î °ú´ÙÇÑ ¹°ÁúÀÌ ÃàÀû, Ä§ÂøÇÏ´Â °Í. ¶ÇÇÑ ÀÌ¿Í °°ÀÌ ÇÏ¿© ÃàÀûµÈ ¹°ÁúÀ» °¡¸®Å°±âµµ ÇÑ´Ù.
  • infiltration anesthesia
    ħÀ± ¸¶Ãë, ħÀ± ¸¶Ãë¹ý, ħÀ±¼º ¹«Åë°¢Áõ
    ÀÛÀº ½Å°æÁ¾ ¸»´Ü ºÎºÐ¿¡ ±¹¼Ò ¸¶Ãë ¾àÀ» ħÀ±½ÃÄÑ ÀÏÀ¸Å°´Â ±¹¼Ò ¸¶Ãë¹ý.
  • inflammatory cell infiltration
    ¿°Áõ ¼¼Æ÷ÀÇ Ä§À±
    ¿°ÁõÀ» ÀÏÀ¸Å°¸é »ýü´Â ¹æ¾îÀûÀ¸·Î Ȱµ¿ÇÏ°í ¿°Áõ ¹°ÁúÀÇ Á¦°Å, ¿°ÁõÀÇ ÁøÀüÀ» ÀúÁöÇϱâ À§ÇØ ÁÖ·Î Ç÷¾×ÁßÀÇ ¹éÇ÷±¸
  • local infiltration
    ±¹¼Ò ħÀ± ¸¶Ãë, ±¹¼Ò ħÀ±, ±¹¼Ò ħÀ±¹ý
  • lymphocytic infiltration
    Àӯı¸ ħÀ±
  • paraneural infiltration
    ½Å°æ ÁÖÀ§ ħÀ± ¸¶Ãë
  • peripheral infiltration
    ÁÖÀ§ Á¶Á÷ ħÀ±
  • acute cellular rejecion
    ±Þ¼º ¼¼Æ÷¼º °ÅºÎ
    ÀϹÝÀûÀ¸·Î ÀÌ½Ä ÈÄ ¼ö °³¿ù ³»¿¡ ¹ß»ýÇϸç Ç÷û Å©·¹¾ÆÆ¼´ÑÄ¡°¡ »ó½ÂÇÏ°í ±Þ¼º ½ÅºÎÀüÀÇ ÀÓ»óÁõ»óÀ» µ¿¹ÝÇÑ´Ù. Á¶Á÷ÇÐÀûÀ¸·Î´Â °£Áú³» ´ÜÇÙ¼¼Æ÷ ħÀ±ÀÌ ¸Å¿ì °­ÇÏ°Ô ³ªÅ¸³ª¸ç, ºÎÁ¾ ¹× °æµµÀÇ °£Áú³» ÃâÇ÷À» º¸À̴µ¥ »ç¶÷ÀÇ °æ¿ì ´ÜÇÙ¼¼Æ÷´Â ÁÖ·Î Áß°£ Å©±â¿Í ÀÛÀº ¸²ÇÁ±¸·Î ±¸¼ºµÇ¾î ÀÖ°í dzºÎÇÑ È£¿°±â¼º ¼¼Æ÷Áú°ú ¼öÆ÷¼º ÇÙÀ» °¡Áø ¼Ò¼öÀÇ ÇüÁú¼¼Æ÷ ħÀ±µµ º¼ ¼ö ÀÖ´Ù.
  • cellular
    ¼¼Æ÷¼º, ¼¼Æ÷ÀÇ
  • cellular adhesiveness
    ¼¼Æ÷ ºÎÂø¼º
    ¼¼Æ÷°£¿¡ ¹°¸®ÀûÀÎ Àη ¶Ç´Â Á¢Ã˹°Ã¼ÀÇ Ç¥¸é°£¿¡ Á¸ÀçÇÏ´Â ºÐÀÚÀη¿¡ ÀÇÇÑ ºÎÂø¼º.
  • cellular antibody
    ¼¼Æ÷ Ç×ü
    ƯÀÌÀûÀÎ ¾Æ¹Ì³ë»ê ¹è¿­À» °¡Áø ¼¼Æ÷¼º ¸é¿ª ±Û·ÎºÒ¸° ºÐÀÚ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
cellular infiltration Migration of cells from their sources of origin, or direct extension of cells as a result of unusual growth and multiplication, thereby resulting in fairly well-defined foci, irregular accumulations, or diffusely distributed individual cells in the connective tissue and interstices of various organs and tissues; used especially with reference to such changes associated with inflammations and certain types of malignant neoplasms.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
adipose infiltration Growth of normal adult fat cells in sites where they are not usually present.
(05 Mar 2000)
calcareous infiltration <biochemistry> The process by which organic tissue becomes hardened by a deposit of calcium salts within its substance.
Origin: L. Facere = to make.
(21 Mar 1998)
gelatinous infiltration A term sometimes used for the relatively rapidly formed, semisolid, gray or gray-white exudate (chiefly necrotic cells and remnants of tissue, and macrophages) resulting from unusually acute, overwhelming, diffuse tuberculous infection in the lung.
Synonym: gelatinous infiltration.
(05 Mar 2000)
paraneural infiltration Infiltration adjacent to or along a nerve.
(05 Mar 2000)
perineural infiltration Infiltration about a nerve.
(05 Mar 2000)
gray infiltration A term sometimes used for the relatively rapidly formed, semisolid, gray or gray-white exudate (chiefly necrotic cells and remnants of tissue, and macrophages) resulting from unusually acute, overwhelming, diffuse tuberculous infection in the lung.
Synonym: gelatinous infiltration.
(05 Mar 2000)
small bowel infiltration <radiology> Whipple disease (proximal small bowel), small bowel lymphoma, amyloidosis, Waldenstrom macrogloblinaemia, sprue, eosinophilic gastroenteritis, abetalipoproteinaemia (increased fat droplets in mucosal cells)
(12 Dec 1998)
infiltration <pathology> The diffusion or accumulation in a tissue or cells of substances not normal to it or in amounts of the normal. Also, the material so accumulated.
(13 Nov 1997)
infiltration anaesthesia Anaesthesia produced by injection of local anaesthetic solution directly into an area that is painful or about to be operated upon.
(05 Mar 2000)
epituberculous infiltration An infiltration superimposed upon a tuberculous lesion.
(05 Mar 2000)
fatty infiltration Abnormal accumulation of fat droplets in the cytoplasm of cells, particularly of fat derived from outside the cells.
See: fatty degeneration.
(05 Mar 2000)
leukaemic infiltration A pathologic change in leukaemia in which leukaemic cells permeate various organs at any stage of the disease. All types of leukaemia show various degrees of infiltration, depending upon the type of leukaemia. The degree of infiltration may vary from site to site. The liver and spleen are common sites of infiltration, the greatest appearing in myelocytic leukaemia, but infiltration is seen also in the granulocytic and lymphocytic types. The kidney is also a common site and of the gastrointestinal system, the stomach and ileum are commonly involved. In lymphocytic leukaemia the skin is often infiltrated. The central nervous system too is a common site.
(12 Dec 1998)
lipomatous infiltration Nonencapsulated adipose tissue forming a lipoma-like mass, usually in the cardiac interatrial septum where it may cause arrhythmia and sudden death.
Synonym: lipomatous hypertrophy.
(05 Mar 2000)
acute cellular rejection Graft rejection which usually begins within 10 days after a graft has been transplanted into a genetically dissimilar host. Lesions at the site of the graft characteristically are infiltrated with large numbers of lymphocytes and macrophages which cause tissue damage.
See: primary rejection.
Synonym: acute rejection.
(05 Mar 2000)
cellular 1. Relating to, derived from, or composed of cells.
2. Having numerous compartments or interstices.
Origin: L. Cellula, dim. Of cella, storeroom
(05 Mar 2000)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
cellular infiltration the migration and accumulation of cells within the tissues.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • infiltration
    ħÅõ
  • cellular
    ¼¼Æ÷ÀÇ
  • cellular
    ¼¼Æ÷ÀÇ,¼¼Æ÷Áú(¸ð¾ç)ÀÇ;¼º±â°Ô § (¼ÅÃ÷µî);´Ù°øÁúÀÇ;ÅëÈ­Á¸(zone)½ÄÀÇ;¼¿ ¹æ½ÄÀÇ(À°»ó À̵¿ Åë½ÅÀÇ »õ·Î¿î ¹æ½Ä)
  • cellular engineering
    ¼¼Æ÷ °øÇÐ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á